BioCardia BCDA
NASDAQ BCDA
$1.02 +0.01 (+0.99%)
At close: Oct 1, 2026 · 4:00 PM EDT

BioCardia (BCDA) Short-term Investments (2017)

Updated

BioCardia (BCDA) reported Short-term Investments of $1.8 million for Q3 2017, up 0.2% from the prior quarter.

Analysis

BioCardia (BCDA) Short-term Investments (2017) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 BioCardia 12.21 Mn -649,799.44 -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2017 1.80 Mn
Jun 30, 2017 1.80 Mn
API Access

BioCardia Short-term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-investments&ticker=BCDA&period=max&api_key=YOUR_API_KEY